B Hurwitz
Overview
Explore the profile of B Hurwitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
1085
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kempster P, Hurwitz B, Lees A
J R Coll Physicians Edinb
. 2017 Jul;
47(2):190-195.
PMID: 28675197
It is 200 years since James Parkinson published An Essay on the Shaking Palsy. While his monograph continues to be acclaimed for its precedence and clarity of description, what is...
2.
Nurmatov U, van Schayck C, Hurwitz B, Sheikh A
Allergy
. 2011 Nov;
67(2):158-65.
PMID: 22103686
Background: To assess the benefits and harms of measures designed to reduce house dust mite (HDM) exposure in the management of house dust mite-sensitive allergic rhinitis. Methods: Systematic review of...
3.
Lovblad K, Anzalone N, Dorfler A, Essig M, Hurwitz B, Kappos L, et al.
AJNR Am J Neuroradiol
. 2009 Dec;
31(6):983-9.
PMID: 20019103
MR imaging is widely used for the diagnosis and monitoring of patients with MS. Applications and protocols for MR imaging continue to evolve, prompting a need for continual reassessments of...
4.
5.
Goodin D, Hurwitz B, Noronha A
J Int Med Res
. 2007 Jun;
35(2):173-87.
PMID: 17542405
The clinical impact of neutralizing antibodies (NAbs) on interferon beta (IFNbeta) efficacy was studied in three large patient cohorts comprising 6698 multiple sclerosis (MS) patients receiving IFNbeta-1b across North America,...
6.
Goodin D, Frohman E, Hurwitz B, OConnor P, Oger J, Reder A, et al.
Neurology
. 2007 Mar;
68(13):977-84.
PMID: 17389300
The clinical and radiologic impact of developing neutralizing antibodies (NAbs) to interferon beta (IFNbeta) while on this therapy for multiple sclerosis (MS) is assessed. On the basis of Class II...
7.
Calderon M, Alves B, Jacobson M, Hurwitz B, Sheikh A, Durham S
Cochrane Database Syst Rev
. 2007 Jan;
(1):CD001936.
PMID: 17253469
Background: Allergic rhinitis is the most common of the allergic diseases. Despite improved understanding of the pathophysiology of allergic rhinitis and advances in its pharmacological treatment, its prevalence has increased...
8.
Sheikh A, Hurwitz B, Shehata Y
Cochrane Database Syst Rev
. 2007 Jan;
(1):CD001563.
PMID: 17253461
Background: In developed countries, it is estimated that approximately 30% of the general population suffer from one or more allergic disorders, of which allergic rhinitis is the most common. Perennial...
9.
Sheikh A, Hurwitz B
Cochrane Database Syst Rev
. 2006 Apr;
(2):CD001211.
PMID: 16625540
Background: There are concerns about whether antibiotic therapy confers significant clinical benefit in the treatment of acute bacterial conjunctivitis. Objectives: The aim of this review was to assess the benefit...
10.
Royal S, Smeaton L, Avery A, Hurwitz B, Sheikh A
Qual Saf Health Care
. 2006 Feb;
15(1):23-31.
PMID: 16456206
Objective: To identify and evaluate studies of interventions in primary care aimed at reducing medication related adverse events that result in morbidity, hospital admission, and/or mortality. Methods: Fourteen electronic databases...